Autism Spectrum Disorder: Understanding and Managing Sensory Crises and Comorbid Depression

This podcast episode, hosted by psychiatrist Dr. Tracey Marks, delves into Autism Spectrum Disorder (ASD), focusing specifically on sensory crises and comorbid depression, prompted by a viewer's question. Dr. Marks begins by tracing the evolution of ASD diagnostic criteria, from "infantile autism" to "pervasive developmental disorder" and "Asperger's Syndrome," culminating in the current unified diagnosis of Autism Spectrum Disorder in 2013. She meticulously outlines the two core diagnostic categories: deficits in social communication and interaction (encompassing issues with reciprocity, non-verbal communication, and relationship maintenance) and restricted, repetitive patterns of behavior, interests, or activities (including stereotyped movements, inflexibility, intense interests, and atypical sensory processing). The discussion emphasizes the diverse presentation of ASD, noting that no two individuals experience it identically, and introduces the concept of hyper- or hypoactivity to sensory input.

The episode then transitions to the management of ASD symptoms, particularly sensory crises and depression. Dr. Marks clarifies that there are no specific medications to treat the core symptoms of ASD, such as communication difficulties or repetitive behaviors. She mentions the two FDA-approved medications, risperidone and aripiprazole, which are neuroleptics used primarily for irritability and aggression in young children with ASD. A promising new drug, balovaptan, currently in Phase 3 clinical trials, is highlighted as a potential future treatment for social problems and extreme social anxiety in ASD. For sensory sensitivity, various medications are used off-label, including alpha agonists (guanfacine, clonidine), other neuroleptics (quetiapine), and anticonvulsants (valproate, lamotrigine, gabapentin). Comorbid depression is typically treated with selective serotonin reuptake inhibitors (SSRIs) like sertraline, fluoxetine, and citalopram, which can also help with obsessional behavior and anxiety.

Dr. Marks addresses the viewer's question about medication curing sensory crises, explaining that while medication can significantly reduce sensitivity, a baseline level of sensitivity often remains, though it becomes more manageable. She stresses the importance of individual self-awareness in identifying specific sensory inputs that are either aggravating or soothing. Practical, non-pharmacological calming techniques are recommended, such as using weighted blankets, compression vests, noise-canceling headphones, and texture toys. The episode also introduces alexithymia, a condition characterized by difficulty recognizing and expressing emotions, which frequently co-occurs with ASD. Dr. Marks explains that behavioral therapies and skills training, rather than medication, are most effective for improving emotional awareness and vocabulary, offering her own "emotions cards" as a tool for this purpose.

In conclusion, the podcast underscores the multifaceted nature of ASD and the necessity of a personalized approach to its management. It highlights the interplay between neurological differences, emotional processing, and environmental stimuli. The discussion reinforces that while pharmacological interventions can alleviate certain symptoms, particularly comorbidities and severe behavioral issues, behavioral strategies, self-awareness, and emotional skills training are crucial for enhancing daily functioning and overall well-being for individuals on the autism spectrum. The ongoing research into new treatments like balovaptan offers hope for future advancements in addressing core ASD challenges, while current strategies focus on symptom management and adaptive coping mechanisms.